Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 January 2025 .Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 2024Powered by Capital Market - Live News

Net Loss of Kabra Drugs reported to Rs 0.40 crore in the quarter ended September 2024 as against net loss of Rs 0.13 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 2024.Powered by Capital Market - Live News